Есть что улучшить? Предложите правку.
Flu vaccine effectiveness (VE) changes every season, depending on how well the vaccine matches circulating viruses and on who is being vaccinated. California can estimate it mid-season, because state law requires labs to report flu test results — positive since October 1, 2019, negative since June 15, 2023 — and, since January 1, 2023, requires providers to record flu shots in the state immunization information system.
A worrying season
From October 1, 2025 to January 31, 2026, flu caused an estimated 22–38 million illnesses, 280,000–590,000 hospitalizations and 12,000–60,000 deaths across the United States; California's season was of moderate severity, like the nation's. There was extra concern this year: an antigenically drifted influenza A(H3N2) subclade K virus was spreading — 92% of genetically characterized U.S. viruses, and 108 of 116 sequenced A(H3N2) viruses (93%) in California.
How the estimate works
The California Department of Public Health (CDPH) compared people aged 6 months and older who tested positive for flu with those who tested negative, and checked how many in each group had a 2025–26 flu shot at least 14 days before testing. If vaccinated people are underrepresented among positives, the vaccine is working. Estimates were adjusted for age, race and ethnicity, week and county.
| Test results | 952,765 |
| Positive | 86,369 (9%) — 96% influenza A, 4% influenza B |
| Vaccinated | 22% of positives, 27% of negatives |
Of influenza A results with a subtype, 76% were A(H3N2) and 24% A(H1N1)pdm09.
The results
| Group | VE against a positive flu test |
|---|---|
| Everyone | 33% |
| Against influenza A | 32% |
| Against influenza B | 47% |
| Under 18 | 39% |
| 18–49 | 34% |
| 50–64 | 31% |
| 65 and older | 22% |
By vaccine type
| Group | Vaccine | VE |
|---|---|---|
| Ages 2–17 | nasal spray (live attenuated, LAIV) | 55% |
| Ages 2–17 | standard-dose shot | 39% |
| 65 and older | recombinant | 39% |
| 65 and older | adjuvanted or high-dose | 22% |
| 65 and older | standard-dose | 16% |
93% of vaccinated adults 65 and older received one of the preferentially recommended vaccines — high-dose, adjuvanted or recombinant.
What it means
- The vaccine protected every age group, most strongly the young, and better against influenza B.
- It still worked against the drifted H3N2 strain; Canada estimated 40% against A(H3N2).
- California's figures match earlier seasons and were shared with local health departments in January 2026 to shape vaccination and treatment messages.
- Everyone 6 months and older should get a flu vaccine each year — and it's not too late while flu is circulating. Early antiviral treatment lowers the risk of severe illness and hospitalization.
Limits: the estimates are early and California-only; test and vaccination data may be incomplete; young children needing two doses may be misclassified as fully vaccinated; there were no data on hospitalization or testing setting; and prior vaccination, health conditions and care-seeking weren't accounted for.
Sources
Based on Sophie Zhu, Joshua Quint, Tomás M. León and others, "Interim Estimates of 2025–26 Seasonal Influenza Vaccine Effectiveness — California, October 2025–January 2026," MMWR, volume 75 (as corrected), Centers for Disease Control and Prevention; a work of the United States government in the public domain.
Лицензия: CC0 1.0 (общественное достояние) · По материалам www.cdc.gov
1
0
0
0
Комментарии
